2nd Quarter - Report

BELL & LINDSAY, INC. (FORMERLY WHITE HOUSE CONSULTING INC.) for ADAGIO THERAPEUTICS, INC.

Firm
Client
Income
$25,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

General Consulting and sharing information about Adagio Therapeutics' covid-19 treatment with federal agencies and Congress.

LobbyistCovered position, as disclosed
ANTHONY JOSEPH FIMOGNARI —
MARK F LINDSAY US House Staff

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Veterans Affairs, Dept of (VA); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.